Aminophylline for COPD exacerbations? Not usually

Thorax

Volumn 60, Issue 9, 2005, Pages 709-

  Town, G I ^a  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR BLOCKING AGENT; AMINOPHYLLINE; PHOSPHODIESTERASE INHIBITOR; PLACEBO; THEOPHYLLINE;

ARTERIAL CARBON DIOXIDE TENSION; ASTHMA; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEATH; DISEASE EXACERBATION; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG METABOLISM; DRUG MONITORING; DRUG WITHDRAWAL; EDITORIAL; EXERCISE TOLERANCE; HEART ARRHYTHMIA; HEART PALPITATION; HUMAN; LENGTH OF STAY; LUNG GAS EXCHANGE; NAUSEA; PRIORITY JOURNAL; SEIZURE; SPIROMETRY; SYSTEMATIC REVIEW; VOMITING;

AMINOPHYLLINE; BRONCHODILATOR AGENTS; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 24744467539     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2005.043760     Document Type: Editorial

References (5)

1. ZuWallack AR, ZuWallack R. Theophylline and phosphodiesterase inhibitors in COPD. In: Celli BR, eds. Pharmacotherapy in chronic obstructive pulmonary disease. Lung Biology in Health & Disease, Volume 182. New York: Marcel Dekker, 2004:239-63.
2. Barr RG, Rowe BH, Camargo Jr CA. Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomized trials. BMJ 2003;327:643-8.
3. National Institute for Clinical Excellence. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004;59(Suppl I):1-232.
4. McKenzie DK, Frith PA, Burdon J, et al. The COPDX Plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease 2003. Med J Aust 2003;178(Suppl):S1-40.
5. Duffy N, Walker P, Diamantea F, et al. Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Thorax 2005;60:713-7.